Skip to content

Diminish attrition risk with iPSC-based safety and toxicity assays

Human iPSC-based tailored assays that provide precise and translational outcomes to confidently advance in the drug discovery pipeline

Get Started

Accurate safety predictions
for higher clinical success

Our team can perform a set of qualified assays to evaluate drug-induced toxicity in a variety of cell models to uncover potential toxic effects earlier in the process.

Consistency and sensitivity

Established cell models
and qualified assays

Translational readouts

Evaluate clinically
relevant cellular functions

Increase success rate

Identify potential toxic effects
early in the process

 

Enlist the safety
screening experts today

As more and more drug discovery innovators look to capitalize on the unique value only iPSCs can deliver, they look to Ncardia as the uniquely qualified collaborator to join them on their all-important journeys. We’re ready to help make your next step the very best it can be. So let’s start with a conversation – about your vision, goals and expectations for your drug discovery projects.

Georgios, Senior scientist Safety screening expert